K. ENOMOTO

Line shapes of optical Feshbach resonances near the intercombination transition of bosonic Ytterbium (2009)

Borkowski, M., Ciurylo, R., Julienne, P. S., Tojo, S., Enomoto, K., Takahashi, Y.

The properties of bosonic Ytterbium photoassociation spectra near the intercombination transition $^{1}S_{0}$--$^{3}P_{1}$ are studied theoretically at ultra low temperatures. We demonstrate how the...

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials (2005)

ABE, O, ABE, R, ENOMOTO, K, KIKUCHI, K, KOYAMA, H, MASUDA, H, ...

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials (2005)

ABE, O, ABE, R, ENOMOTO, K, KIKUCHI, K, KOYAMA, H, MASUDA, H, ...

A phase I/II study of continuous intra-arterial chemotherapy using an implantable reservoir for the treatment of liver metastases from breast cancer: a Japan Clinical Oncology Group (JCOG) study 9113. JCOG Breast Cancer Study Group (1999)

Ikeda, T, Adachi, I, Takashima, S, Ogita, M, Aoyama, H, Sano, M, ...

Chronic liver injury promotes hepatocarcinogenesis of the LEC rat (1998)

Sawaki, M, Hattori, A, Tsuzuki, N, Sugawara, N, Enomoto, K, Sawada, N, ...

Ovarian ablation in early breast cancer: Overview of the randomised trials. (1996)

CLARKE, M, COLLINS, R, DAVIES, C, GODWIN, J, GRAY, R, PETO, R, ...

MX2; 3'-deamino-3'-morpholino-13-deoxy-10-hydroxycarminomycin (KRN8602) in refractory metastatic breast cancer: results of a preliminary phase II trial (1993)

Watanabe, T, Narabayashi, M, Haga, S, Yamada, Y, Kawamura, E, Enomoto, K, ...

SYSTEMIC TREATMENT OF EARLY BREAST-CANCER BY HORMONAL, CYTOTOXIC, OR IMMUNE THERAPY - 133 RANDOMIZED TRIALS INVOLVING 31000 RECURRENCES AND 24000 DEATHS AMONG 75000 WOMEN .2. (1992)

ABE, O, ABE, R, ASAISHI, K, ENOMOTO, K, HATTORI, T, INO, Y, ...